1-3 of 3
Yoshiaki Tomiyama
Close
Sort by
Journal Articles

Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study

Clinical Trials & Observations
Kinuko Mitani, Jong Wook Lee, Jun Ho Jang, Yoshiaki Tomiyama, Koji Miyazaki, Koji Nagafuji, Kensuke Usuki, Nobuhiko Uoshima, Tomoaki Fujisaki, Hiroshi Kosugi, Itaru Matsumura, Ko Sasaki, Masahiro Kizaki, Masashi Sawa, Michihiro Hidaka, Naoki Kobayashi, Satoshi Ichikawa, Yuji Yonemura, Kenta Murotani, Mami Shimizu, Akira Matsuda, Keiya Ozawa, Shinji Nakao
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1415–1419.
https://doi.org/10.1182/bloodadvances.2023010959
Published: 2024
Includes: Supplemental data
Journal Articles

Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan

Clinical Trials & Observations
Takaaki Hato, Naoki Shimada, Yoshiyuki Kurata, Masataka Kuwana, Kingo Fujimura, Hirokazu Kashiwagi, Toshiro Takafuta, Mitsuru Murata, Yoshiaki Tomiyama
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1648–1655.
https://doi.org/10.1182/bloodadvances.2020001446
Published: 2020
Journal Articles

Updated international consensus report on the investigation and management of primary immune thrombocytopenia

Drew Provan, Donald M. Arnold, James B. Bussel, Beng H. Chong, Nichola Cooper, Terry Gernsheimer, Waleed Ghanima, Bertrand Godeau, Tomás José González-López, John Grainger, Ming Hou, Caroline Kruse, Vickie McDonald, Marc Michel, Adrian C. Newland, Sue Pavord, Francesco Rodeghiero, Marie Scully, Yoshiaki Tomiyama, Raymond S. Wong, Francesco Zaja, David J. Kuter
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3780–3817.
https://doi.org/10.1182/bloodadvances.2019000812
Published: 2019
Includes: Supplemental data